
According to the Union Health Ministry, spinal muscular atrophy is a rare genetic disorder that affects nerve cells in the spinal cord, causing muscle weakness in the limbs and trunk.
| Photo Credit: Getty Images
Delhi University on Friday approved a proposal to provide ₹17 crore in financial assistance for the treatment of the nine-month-old daughter of a faculty member at the School of Open Learning (SOL). The child has spinal muscular atrophy (SMA) Type II, a rare genetic disorder.
SOL officials said Vice-Chancellor Yogesh Singh had constituted a special committee, which recommended the financial assistance.
Before the decision, the SOL Academic Association had launched a crowdfunding initiative that raised ₹3.11 crore through contributions from the Tata Trust, the Chief Minister’s Relief Fund, online platforms such as Impact Guru, Milaap, Ketto and GoFundMe, the Teacher Relief Fund and SOL’s non-academic staff association.
Payal Mago, Director of SOL, said the coordinated efforts of university faculty and prompt action had helped secure financial assistance for the child’s treatment within the required timeframe. She said any delay could have put the child’s life at risk.
According to the Union Health Ministry, SMA is a rare genetic disorder that affects nerve cells in the spinal cord, causing muscle weakness in the limbs and trunk. New treatment options have improved the outlook for patients with the condition.
Symptoms of SMA Type I typically appear before six months of age, causing muscle weakness and limited limb movement. Without treatment, affected children may die of respiratory failure before the age of two.
Type II manifests between six months and two years of age. Affected children can sit unaided but generally require wheelchairs and often develop spinal deformities after adolescence. Those who develop the condition later in childhood or adulthood may remain mobile for longer.
Published – November 13, 2026 07:32 pm IST